Helport AI Opens Thailand Office 
playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo 
Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter 
Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future XcelPlus International completes $1 million seed funding round, adds Ford Seeman to Board of Directors
Reno, NV, July 27, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC Pink: XLPI) announced…
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
Bone Therapeutics to focus in future on the development of its MSC cell and gene…
Spectral Medical Inc. Closes $10 Million Offering of Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
Sunshine Biopharma Opens Twitter Account For Increased Shareholder Engagement
MONTREAL, July 27, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.
Pompano Beach, Fl., July 27, 2021 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC PINK: BSEM)…
Medicenna Announces That Initiation of MDNA11 Phase 1/2 Study is on Track; Update to be Provided at the PropThink Digital Conference
–Â Phase 1/2 ABILITY Study is designed to evaluate MDNA11, a potentially best-in-class IL-2 Superkine,…
Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield”  to Discuss Concussion Treatments
IRVINE, CA, July 27, 2021 (GLOBE NEWSWIRE) — Â Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company”…
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent
Potential for Affordable COVID-19 Immunization Coverage in Underserved African Countries Arrangement includes C1 COVID-19 vaccine…
Cidara Therapeutics to Present New Data for Rezafungin at the International Society for Human and Animal Mycology (ISHAM) Asia Congress
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Rhythm Pharmaceuticals to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
BOSTON, July 27, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed…
Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021
Management to host conference call and webcast at 8:30 AM ET on that day NEVE…
BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad CatĂłlica de Chile
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Radius Health Business Update
Added 5,000+ new TYMLOS patients in Q2, 2021, up 40+% vs. Q2, 2020 and 3%…
Kronos Bio Announces FDA Clearance of Investigational New Drug Application for Lanraplenib (LANRA) for Treatment of Patients with Acute Myeloid Leukemia (AML)
Company intends to develop LANRA as a once-daily chronic treatment for genetically-defined AML patients Two…
VYNE Therapeutics to Report Second Quarter 2021 Financial Results on August 12, 2021
BRIDGEWATER, N.J., July 27, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
       – First clinical trial to specifically study confirmed carbapenem-resistant Acinetobacter…
Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (“TLIS”), a company…
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
AFFiRiS to receive AC Immune stock valued at USD 58.7 million in exchange for its…
LAVA Therapeutics Announces Appointment of Amy Garabedian as General Counsel and Corporate Secretary
UTRECHT, The Netherlands and PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…